Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASH: Asymptomatic BV and HSV-2 Shedding
NCT00464542Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Dec 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metronidazole in bacterial vaginosis (BV), sponsored by University of Pittsburgh. Primary endpoint: Number of Participants With Bacterial Vaginosis Recurrence. Started Dec 2007; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT00464542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464542.